Shares of pharmaceutical giant Amgen (AMGN) are attempting to bounce back after suffering a steep drop of 7.1% yesterday.

The Act curbs US-China biotech collaborations, spurring opportunities for emerging markets in pharma supply chains.

AbbVie’s deal flop and NFL high-profile draft busts have a lot in common.

STAT gathered reactions from leaders across biotech and pharma about what the new Trump era could mean for them.

This health news summary explores various pharmaceutical developments including Novo Nordisk's phasing out of insulin pens, a ...

Villagers have been fighting for justice for about nine months, yet neither the Chief Minister nor his officials had ...

Nuvectis Pharma shares fell steeply after updated data from its early-stage study evaluating NXP800 to treat an aggressive type of ovarian cancer showed that a change in the dosing schedule only ...

Glenmark Pharma continued to benefit from its strong position in key chronic therapy areas, including respiratory and dermatology therapeutics, according to its latest, opens new tab annual report.

BRS spokesperson Manne Krishank gave a strong counter to the claims of Medicover Hospitals that the hospital had no links ...

For Q2, the company’s revenue from the Indian market rose 13.9 per cent to Rs 1,281.7 crore, contributing 37 per cent to ...

Ascendis Pharma (ASND) has released an update. Ascendis Pharma A/S has structured its capital to enable significant growth opportunities, with ...

Ascendis Pharma (ASND) is scheduled to announce Q3 earnings results on Thursday, November 14th, after market close. The ...